LINEZOLIDIN
The image of the packaging corresponds to the packaging currently registered with the regulatory authorities of Ukraine.
In case of any discrepancies, please contact us at tel. +380 44 490 75 22
Solution for injection 300 ml №1.
The image of the packaging corresponds to the packaging currently registered with the regulatory authorities of Ukraine.
In case of any discrepancies, please contact us at tel. +380 44 490 75 22
-
Treatment of infections caused by susceptible strains of aerobic and anaerobic gram-positive bacteria, including infections, accompanied by bacteremia, such as: nosocomial pneumonia; community acquired pneumonia; complicated infections of the skin and its structures, particularly infections secondary to the diabetic foot without concomitant osteomyelitis, caused by Staphylococcus aureus (methicillin-sensitive and methicillin-resistant isolates), Streptococcus pyogenes, or Streptococcus agalactiae; uncomplicated infections of the skin and its structures caused by Staphylococcus aureus (methicillin-sensitive isolates only) or Streptococcus pyogenes; infections caused by enterococci, including vancomycin-resistant strains of Enterococcus faecium and faecalis. If infection pathogens include gram-negative bacteria, combination therapy is clinically indicated.
-
1 ml of solution contains linezolid 2 mg.
